Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19

Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19

SABCS

2 months
13 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Gerardo Antonio Umanzor, MD of Liga Contra el Cáncer on paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: a Phase III clinical study in metastatic breast cancer.

Up Next Autoplay